Evidence map›Paper›PMID 36551420›Full record

ArticleAntibiotics (Basel, Switzerland)2022

In Vitro Study on Green Propolis as a Potential Ingredient of Oral Health Care Products.

Achille Coluccia, Fabienne Matti, Xilei Zhu, Adrian Lussi, Alexandra Stähli, Anton Sculean, Sigrun Eick

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Achille ColucciaDepartment of Periodontology, School of Dental Medicine, University of Bern, 3010 Bern, Switzerland.
Fabienne MattiDepartment of Periodontology, School of Dental Medicine, University of Bern, 3010 Bern, Switzerland.
Xilei ZhuDepartment of Periodontology, School of Dental Medicine, University of Bern, 3010 Bern, Switzerland.
Adrian LussiPreventive and Paediatric Dentistry, School of Dental Medicine, University of Bern, 3010 Bern, Switzerland.
Alexandra StähliDepartment of Periodontology, School of Dental Medicine, University of Bern, 3010 Bern, Switzerland.
Anton SculeanDepartment of Periodontology, School of Dental Medicine, University of Bern, 3010 Bern, Switzerland.
Sigrun EickDepartment of Periodontology, School of Dental Medicine, University of Bern, 3010 Bern, Switzerland.ORCID 0000-0002-4619-2461
University of Bern · CH

Funding

Association for Dental Infection Control 2018/4
6 · The paper itself

Abstract

Propolis is increasingly being discussed as an alternative to commonly used antiseptics. This in vitro study focused on the ethanolic extract of green Brazilian propolis (EEPg) as an additive in an oral health care product. We investigated (i) a potential inflammation-modulation activity of EEPg when a periodontal or Candida biofilm was exposed to monocytic (MONO-MAC-6) cells, (ii) the adhesion of oral pathogens to gingival keratinocytes and (iii) the antimicrobial and antibiofilm effect of different toothpaste formulations. EEPg decreased the levels of interleukin (IL)-1β and increased IL-10 in MONO-MAC cells challenged with a periodontal biofilm. In contact with TIGK cells, EEPg reduced the numbers of adherent

Indexed as

biofilmBrazilian green propolismonocytic cellstoothpaste

Identifiers

PMID36551420
PMCPMC9774696
OpenAlexW4311720675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.